Maintaining Patency in BioFlo Implanted Port Catheters With Saline Only Flushes
Maintaining Patency in BioFlo Implanted Port Catheters With Saline Only Flushes
The purpose of this study is to determine the safest and most effective flushing solution for
 maintaining patency (unobstructed flow) in BioFlo implanted port catheters. The complication
 rate in patients whose ports are flushed with saline only will be compared to the
 complication rate in patients whose ports are flushed with a combination of saline and
 heparinized saline.
The purpose of this study is to determine the safest and most effective flushing solution for
 maintaining patency (unobstructed flow) in BioFlo implanted port catheters. The complication
 rate in patients whose ports are flushed with saline only will be compared to the
 complication rate in patients whose ports are flushed with a combination of saline and
 heparinized saline. These complications include partial or complete obstruction, infection of
 the central line, and/or the onset of heparin induced thrombocytopenia.
Inclusion Criteria:

 -  Able to read and understand English

 -  Has a BioFlo implanted port in place less than one (1) year

 -  Evidence of a patent BioFlo port catheter prior to enrollment in the study

 -  Is receiving active treatment (i.e., receiving a therapeutic drug) through the BioFlo
 implanted port

 -  Current treatment protocol projected to continue for a minimum of three (3) months

 -  Anticipates receiving care at the identified centers for 12 months following
 enrollment in the study

 -  Does not receive care of BioFlo implanted port at any other facility

 Exclusion Criteria:

 -  Has documented heparin platelet antibody (i.e., could not be randomized to either
 group) or other allergy to heparin

 -  Receiving therapeutic dose of an anticoagulant (e.g.,warfarin, heparin, enoxaparin)

 -  Does not meet one or more of the inclusion criteria